Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
160M
-
Shares change
-
-103K
-
Total reported value, excl. options
-
$8.12B
-
Value change
-
-$5.22M
-
Put/Call ratio
-
1.04
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$50.63
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q4 2013
245 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q4 2013.
INCYTE CORP - COMMON STOCK (INCY) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160M shares
of 194M outstanding shares and own 82.84% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (24M shares), Capital World Investors (18.8M shares), BAKER BROS. ADVISORS LP (14.8M shares), WELLINGTON MANAGEMENT CO LLP (8.6M shares), VANGUARD GROUP INC (8.02M shares), Artisan Partners Limited Partnership (7.03M shares), BB Biotech AG (4.22M shares), ORBIMED ADVISORS LLC (4.07M shares), BROWN CAPITAL MANAGEMENT LLC (3.75M shares), and JENNISON ASSOCIATES LLC (3.53M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.